Impact
The Oracle Life Sciences Central Designer product contains an unauthenticated vulnerability that allows an attacker with network access via HTTP to read restricted data. The weakness is a confidential data exposure and is classified as CWE-200. Successful exploitation results in unauthorized read access to a subset of data that should not be available without proper authentication. The impact is limited to confidentiality; integrity and availability are not affected.
Affected Systems
Oracle Life Sciences Central Designer version 7.0.1.0 is affected. Any deployment of this product running that specific version is susceptible to the vulnerability.
Risk and Exploitability
The CVSS v3.1 base score is 5.3 with a low exploitation difficulty (AC:L) and no user interaction (UI:N). The EPSS score is < 1%, indicating a very low estimated probability of exploitation at the time of analysis, and the vulnerability is not listed in the CISA KEV catalog. The likely attack vector is over the network via an unauthenticated HTTP request, and an attacker must have network reach to the application server to leverage the flaw.
OpenCVE Enrichment